Tower Research Capital (TRC)’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$464K Sell
19,404
-27,921
-59% -$683K 0.01% 963
2025
Q4
$1.07M Buy
47,325
+34,400
+266% +$749K 0.03% 492
2025
Q3
$260K Buy
12,925
+12,834
+14,103% +$215K 0.01% 1283
2025
Q2
$1.3K Sell
91
-1,878
-95% -$21.9K ﹤0.01% 4832
2025
Q1
$20.7K Sell
1,969
-1,957
-50% -$22.1K ﹤0.01% 2929
2024
Q4
$47.5K Sell
3,926
-14,762
-79% -$193K ﹤0.01% 2588
2024
Q3
$275K Sell
18,688
-4,691
-20% -$65.4K 0.01% 1331
2024
Q2
$337K Buy
23,379
+16,669
+248% +$266K 0.01% 1655
2024
Q1
$109K Buy
6,710
+498
+8% +$7.79K ﹤0.01% 1778
2023
Q4
$92.6K Buy
6,212
+3,906
+169% +$44.2K ﹤0.01% 2705
2023
Q3
$25.9K Sell
2,306
-4,242
-65% -$49.3K ﹤0.01% 3143
2023
Q2
$65.9K Sell
6,548
-14,802
-69% -$137K ﹤0.01% 2354
2023
Q1
$201K Buy
21,350
+16,956
+386% +$200K 0.01% 1372
2022
Q4
$53K Sell
4,394
-46,957
-91% -$585K ﹤0.01% 2300
2022
Q3
$638K Buy
51,351
+34,022
+196% +$595K 0.01% 952
2022
Q2
$340K Sell
17,329
-26,776
-61% -$634K 0.01% 1388
2022
Q1
$1.15M Sell
44,105
-14,667
-25% -$391K 0.01% 733
2021
Q4
$1.67M Buy
58,772
+17,390
+42% +$541K 0.03% 489
2021
Q3
$1.32M Buy
41,382
+4,763
+13% +$160K 0.03% 401
2021
Q2
$1.27M Sell
36,619
-9,103
-20% -$300K 0.03% 502
2021
Q1
$1.35M Buy
45,722
+39,051
+585% +$1.2M 0.02% 625
2020
Q4
$204K Buy
6,671
+1,182
+22% +$36.1K 0.01% 1691
2020
Q3
$153K Sell
5,489
-52,231
-90% -$1.32M ﹤0.01% 2805
2020
Q2
$1.24M Buy
57,720
+55,706
+2,766% +$1.23M 0.05% 397
2020
Q1
$45K Buy
+2,014
New +$55.2K ﹤0.01% 1338
2019
Q4
Sell
-1,997
Closed -$53K 3736
2019
Q3
$53K Sell
1,997
-2,163
-52% -$64.9K ﹤0.01% 1755
2019
Q2
$141K Sell
4,160
-991
-19% -$32.2K 0.01% 1008
2019
Q1
$165K Sell
5,151
-225
-4% -$6.92K 0.01% 1208
2018
Q4
$170K Sell
5,376
-1,032
-16% -$33.8K 0.01% 749
2018
Q3
$224K Buy
+6,408
New +$225K 0.02% 918

Other funds holding ELAN